 | Up a level |
Macdonald, R. Loch; Higashida, Randall T.; Keller, Emanuela; Mayer, Stephan A.; Molyneux, Andy; Raabe, Andreas; Vajkoczy, Peter; Wanke, Isabel; Bach, Doris; Frey, Aline; Marr, Angelina; Roux, Sébastien; Kassell, Neal (2013). Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta neurochirurgica - supplementa, 115, pp. 27-31. Springer 10.1007/978-3-7091-1192-5_7
Macdonald, R Loch; Higashida, Randall T; Keller, Emanuela; Mayer, Stephan A; Molyneux, Andy; Raabe, Andreas; Vajkoczy, Peter; Wanke, Isabel; Bach, Doris; Frey, Aline; Nowbakht, Pegah; Roux, Sébastien; Kassell, Neal (2012). Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke, 43(6), pp. 1463-9. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/STROKEAHA.111.648980
Macdonald, R Loch; Higashida, Randall T; Keller, Emanuela; Mayer, Stephan A; Molyneux, Andy; Raabe, Andreas; Vajkoczy, Peter; Wanke, Isabel; Frey, Aline; Marr, Angelina; Roux, Sébastien; Kassell, Neal F (2010). Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocritical care, 13(3), pp. 416-24. New York, N.Y.: Springer 10.1007/s12028-010-9433-3
